Product image of Merozan (Meropenem) supplied by GNH India

Merozan

Active Ingredient:
Meropenem
Origin:
EU

Merozan (Meropenem)

Meropenem, the active ingredient in Merozan, is a carbapenem presented as an injectable solution for intravenous use. It is employed to treat severe bacterial infections in hospitalized patients, including intra‑abdominal infections, hospital‑acquired pneumonia, and sepsis. The drug is active against a broad range of Gram‑negative and Gram‑positive organisms, including strains resistant to other β‑lactam antibiotics.

GNH India supplies Merozan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Manufacturer / TM Owner

Demo Abee

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Merozan (meropenem) is used for serious bacterial infections where broad‑spectrum coverage is required.

  • Severe bacterial infections: provides rapid bactericidal activity to control life‑threatening infections.
  • Complicated intra‑abdominal infections: eradicates mixed aerobic and anaerobic pathogens after surgical intervention.
  • Hospital‑acquired pneumonia: treats ventilator‑associated and other nosocomial pneumonias caused by resistant organisms.
  • Sepsis: delivers systemic antimicrobial effect to support hemodynamic stabilization in septic patients.

How It Works

  • Meropenem exerts its antibacterial effect by binding to penicillin‑binding proteins (PBPs) located on the bacterial cell wall. This binding inhibits the final transpeptidation step of peptidoglycan synthesis, weakening the cell wall and leading to osmotic lysis and bacterial death. Its high affinity for multiple PBPs gives it activity against a wide spectrum of Gram‑negative and Gram‑positive bacteria, including many β‑lactam‑resistant strains.

Side Effects

Like all antibiotics, meropenem may cause adverse reactions that vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: may be watery and self‑limiting.
  • Headache: transient and usually resolves without intervention.
  • Infusion site reactions: erythema, pain, or phlebitis at the injection site.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disorders.
  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Clostridioides difficile‑associated diarrhea: can lead to colitis and requires prompt treatment.

Precautions & Warnings

Prior to initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

  • Renal function: adjust dose in patients with impaired renal clearance.
  • Hypersensitivity: avoid in individuals with known carbapenem allergy.
  • Seizure risk: monitor closely in patients with a history of seizures or CNS disease.
  • Pregnancy: use only when the potential benefit justifies the potential risk to the fetus.
  • Concomitant valproic acid: may increase the risk of seizures; consider alternative therapy.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Meropenem can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Valproic acid: may increase the risk of seizures.
  • Probenecid: reduces renal excretion of meropenem, raising plasma levels.
  • High‑dose aminoglycosides: additive nephrotoxicity.

Moderate Interactions (Monitor Closely)

  • Diuretics: may affect renal clearance of meropenem.
  • Other nephrotoxic agents (e.g., vancomycin): monitor kidney function.
  • Oral contraceptives: possible reduction in contraceptive effectiveness; advise additional contraceptive measures.

Frequently Asked Questions

Merozan contains meropenem, a carbapenem antibiotic indicated for the treatment of severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, sepsis and other serious infections caused by susceptible Gram‑negative and Gram‑positive organisms.

Meropenem binds to penicillin‑binding proteins on the bacterial cell wall, blocking the final step of peptidoglycan cross‑linking. This inhibition weakens the wall, causing osmotic rupture and bacterial death, providing rapid bactericidal activity against a broad spectrum of pathogens.

The dosage of Merozan is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function and other clinical factors. No fixed regimen is provided here; the prescriber sets the appropriate dose and infusion rate.

Safety data for meropenem in pregnancy and lactation are limited. Use is recommended only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and should be decided by a qualified healthcare professional.

To request Merozan, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Merozan (meropenem) offers a broad spectrum of activity similar to other carbapenems such as imipenem‑cilastatin and ertapenem, but it has a slightly lower propensity for inducing seizures and is stable against many β‑lactamases. Choice among carbapenems depends on infection type, pathogen susceptibility, renal function and local antimicrobial stewardship guidelines.

Merozan should be stored at 2‑8 °C in a refrigerator, protected from light and moisture. Do not freeze the product. Once reconstituted, use the solution according to the manufacturer’s instructions and discard any unused portion after the recommended in‑use period.

Merozan is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional through a peripheral or central line, typically over a 15‑30 minute infusion, with dosing intervals determined by the prescriber based on infection severity and renal function.

The most serious adverse events include seizures, especially in patients with renal impairment or pre‑existing CNS disorders, and severe hypersensitivity reactions such as anaphylaxis. Clinicians should also monitor for Clostridioides difficile‑associated colitis, which can be life‑threatening if not treated promptly.

Merozan is contraindicated in patients with a known hypersensitivity to meropenem, other carbapenems, or any component of the formulation. Caution is also advised for patients with a history of seizures, severe renal impairment without dose adjustment, or those receiving valproic acid.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT